News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ICOS Corporation (ICOS) Special Meeting Adjourned And Scheduled To January 25, 2007



12/19/2006 2:59:30 PM

BOTHELL, Wash.--(BUSINESS WIRE)--ICOS Corporation (NASDAQ: ICOS) announced that its special meeting of shareholders, held today, was adjourned and has been scheduled to January 25, 2007, to give shareholders time to evaluate and vote on the revised Agreement and Plan of Merger, which was announced yesterday. The revised Agreement and Plan of Merger provides that Eli Lilly and Company (NYSE:LLY) will acquire all of the outstanding common stock of ICOS for a purchase price of $34 per share in cash, increased from the previous $32 per share. A new proxy statement will be distributed to shareholders that will include a description of the amended agreement, a copy of Merrill Lynch’s fairness opinion and related disclosures.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES